MENDRA
LIVE

Serial Number

99658639

Owner

Mendra, Inc.

Attorney

Mark A. Jansen

Filing Date

Feb 18, 2026

Add to watchlist:

No watchlists yet
View on USPTO

MENDRA Trademark

Serial Number: 99658639

MENDRA is a trademark filed by Mendra, Inc. on February 18, 2026. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Mendra, Inc.

4 Embarcadero Center, Suite 3110
San Francisco, CA 94111

Entity Type: 03

Trademark Details

Filing Date

February 18, 2026

Registration Date

Not Registered

Goods & Services

Pharmaceutical preparations and substances; therapeutic and prophylactic pharmaceutical products; medicines for the treatment and prevention of rare diseases, autoimmune diseases, inflammatory diseases, and infectious diseases and disorders; pharmaceutical products for use in medical research and clinical development; pharmaceutical products in development for regulatory approval

downloadable artificial intelligence software for use with rare diseases; downloadable artificial intelligence software for use in the field of medicine and medical research; downloadable artificial intelligence (AI) software for use in pharmaceutical research, drug discovery, clinical development, regulatory analysis, data analysis, and commercialization; downloadable software for collecting, analyzing, searching, and managing biomedical, clinical, and scientific data; downloadable software platforms for identifying, evaluating, and developing pharmaceutical and therapeutic assets, including software for rare disease research; downloadable software for identifying and recruiting clinical trial participants; downloadable software for managing global regulatory submissions and market access data; downloadable software for mapping and forecasting rare disease populations; downloadable software for facilitating real-time collaboration in pharmaceutical development and commercialization; downloadable artificial intelligence software for developing treatments and drugs for treating rare diseases

Scientific research and development services in the fields of pharmaceuticals, therapeutics, and medicine; research and development of pharmaceutical products, therapies, and treatments; biomedical research services; pharmaceutical research and clinical development services; providing online non-downloadable software artificial intelligence software for use with rare diseases; providing online non-downloadable software artificial intelligence software for use in the field of medicine and medical research; providing online non-downloadable software artificial intelligence (AI) software for use in pharmaceutical research, drug discovery, clinical development, regulatory analysis, data analysis, and commercialization; providing online non-downloadable software for collecting, analyzing, searching, and managing biomedical, clinical, and scientific data; providing online non-downloadable software for identifying, evaluating, and developing pharmaceutical and therapeutic assets, including software for rare disease research; providing non-downloadable artificial intelligence software for use in pharmaceutical research, rare disease analysis, asset evaluation, clinical development, and commercialization; providing online non-downloadable software for searching, aggregating, analyzing, and modeling biomedical, clinical, and pharmaceutical data; providing temporary use of online, non-downloadable software for identifying and recruiting clinical trial participants; providing temporary use of online, non-downloadable software for managing global regulatory submissions and market access data; providing temporary use of online, non-downloadable software for mapping and forecasting rare disease populations; providing temporary use of online, non-downloadable software for facilitating real-time collaboration in pharmaceutical development and commercialization; providing temporary use of online, non-downloadable artificial intelligence software for developing treatments and drugs for treating rare diseases

Medical research and development services; providing medical and scientific information in the field of rare diseases; providing health and medical information relating to diseases, disorders, diagnosis, treatment, and prevention; medical advisory services relating to pharmaceutical research and development; Consulting services in the field of rare disease drug development; Prevention, diagnostics, treatment, and therapy for rare diseases

Filing History

NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 16, 2026 GNRN
NON-FINAL ACTION E-MAILED
Jun 16, 2026 GNRT
NON-FINAL ACTION WRITTEN
Jun 16, 2026 CNRT
ASSIGNED TO EXAMINER
Jun 15, 2026 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 14, 2026 NWOS
APPLICATION FILING RECEIPT MAILED
Feb 18, 2026 MAFR
NEW APPLICATION ENTERED
Feb 18, 2026 NWAP